A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA

BACKGROUND: Early screening for prostate cancer (PCA) remains controversial because of overdiagnosis and overtreatment of clinically insignificant cancers. Even though a number of diagnostic tests have been developed to improve on PSA testing, there remains a need for a more informative non-invasive...

Descripción completa

Detalles Bibliográficos
Autores principales: Brikun, Igor, Nusskern, Deborah, Decatus, Andrew, Harvey, Eric, Li, Lin, Freije, Diha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029393/
https://www.ncbi.nlm.nih.gov/pubmed/29988684
http://dx.doi.org/10.1186/s13148-018-0524-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029393/
https://www.ncbi.nlm.nih.gov/pubmed/29988684
http://dx.doi.org/10.1186/s13148-018-0524-x

Ejemplares similares